<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="pandemic of the disease once it has been acquired [26,28]." exact="SARS-CoV-2 infection" post="is primarily thought to transmit from human-to-human among individuals"/>
 <result pre="review, there are no specific therapeutic regimens approved for treating" exact="SARS-CoV-2 infection." post="The development of novel compounds or vaccines that work"/>
 <result pre="the moment in the standard clinical practices of China for" exact="SARS-CoV-2 infection" post="[27]. However, the validity of using these compounds should"/>
 <result pre="the fast solution to act against the invasive spread of" exact="SARS-CoV-2 infection." post="Several drugs have been used before to control and"/>
 <result pre="in improving patients' survival and reducing the viral load of" exact="SARS-CoV-2 infection" post="[77]. The investigations include antiviral drugs such as lopinavir,"/>
 <result pre="Jin Yin-Tan Hospital, Wuhan, on 199 seriously ill patients of" exact="SARS-CoV-2 infection" post="[80]. Male and nonpregnant patients of 18Â years or"/>
 <result pre="validate further the role of FPV in the management of" exact="SARS-CoV-2 infection" post="(NCT04303299, NCT04310228 and NCT04273763). FPV is being investigated as"/>
 <result pre="A clinical case study for the first patient diagnosed with" exact="SARS-CoV-2 infection" post="in USA has shown promising effectiveness of RDV [74]."/>
 <result pre="currently one of the most promising antiviral agents for reversing" exact="SARS-CoV-2 infection." post="Currently, about seven clinical trials are registered for investigating"/>
 <result pre="is recruiting patients to determine the efficacy of RBV for" exact="SARS-CoV-2 infection" post="at the University of Hong Kong, Queen Mary Hospital."/>
 <result pre="[91]. Arbidol is another antiviral that is being considered for" exact="SARS-CoV-2 infection." post="A retrospective study from the Fifth Affiliated Hospital of"/>
 <result pre="is currently being investigated extensively for its promising activity against" exact="SARS-CoV-2 infection" post="[96,97]. CQ is an old antimalarial drug with limited"/>
 <result pre="Trial Registry to test the CQ or HCQ efficiency on" exact="SARS-CoV-2 infection" post="[97]. The clinical outcomes include time to clinical recovery,"/>
 <result pre="and tolerability of tocilizumab in the treatment of patients with" exact="SARS-CoV-2 infection." post="Tocilizumab is to be injected as two doses, 8Â"/>
 <result pre="tocilizumab versus FPV alone versus tocilizumab alone for treatment of" exact="SARS-CoV-2 infection" post="[117]. Sarilumab is another IL-6 blocker that is used"/>
 <result pre="be considered while repurposing the use of this drug for" exact="SARS-CoV-2 infection." post="Other immunomodulators are being considered, including adalimumab. As mentioned"/>
 <result pre="response that is the main factor inducing lung damage in" exact="SARS-CoV-2 infection." post="On the other hand, corticosteroids may suppress the immune"/>
 <result pre="and died [27]. A study included 80 patients with confirmed" exact="SARS-CoV-2 infection" post="received treatment of a single antibiotic (moxifloxacin) and RBV"/>
 <result pre="[28]. Another study was conducted on 46 patients with confirmed" exact="SARS-CoV-2 infection" post="who received standard care of oxygen, cough relief, antiviral"/>
 <result pre="trials yet) The discovery and development of new molecules against" exact="SARS-CoV-2 infection" post="need time [129]. Besides, in silico discovery of molecules"/>
 <result pre="several research groups and pharmaceutical companies from the beginning of" exact="SARS-CoV-2 infection." post="The selection of these potential therapies was based on"/>
 <result pre="the anti-inflammatory drug is a choice for viral infections, including" exact="SARS-CoV-2 infection." post="Few studies discussed anti-inflammatory therapies as an option to"/>
 <result pre="anti-inflammatory therapies as an option to reduce the symptoms of" exact="SARS-CoV-2 infection" post="with baricitinib, and melatonin being the most related [131]."/>
 <result pre="screening for anti-inflammatory drugs that could be potential therapies for" exact="SARS-CoV-2 infection" post="[132]. SAR-COV-2 enters lung cells by ACE2-mediated invasion. AP2-associated"/>
 <result pre="as a potential anti-inflammatory drug to relieve the symptoms of" exact="SARS-CoV-2 infection." post="Viral infections cause injury of the immune system that"/>
 <result pre="effect and has been previously encouraged to be used for" exact="Ebola" post="viral infection [134]. As suggested by ChengÂ et al.,"/>
 <result pre="ChengÂ et al., melatonin could reduce the clinical symptoms of" exact="SARS-CoV-2 infection" post="and prolong the survival time for the patient. Angiotensin"/>
 <result pre="studies, it is still unclear how ACE2 is modified in" exact="SARS-CoV-2 infection" post="[32,135]. Kruse has suggested that therapies that block the"/>
 <result pre="receptor domain could be studied for their potential effectiveness against" exact="SARS-CoV-2 infection" post="[136]. For example, using the small receptor-binding domain (RBD)"/>
 <result pre="emodin or promazine could be considered as potential therapeutics for" exact="SARS-CoV-2 infection." post="Protease inhibitors Having coronaviral principal protease (3CLpro) as the"/>
 <result pre="effect for the function of proteases 3CLpro and Plpro in" exact="SARS-CoV infection" post="[141]. These candidates are also undergoing studies in research"/>
 <result pre="Î±-ketoamide inhibitor and considered Î±-ketoamide inhibitors as promising agents for" exact="SARS-CoV-2 infection" post="[140]. Traditional Chinese medicines therapy Traditional Chinese medicines (TCMs)"/>
 <result pre="infections, could be potential therapies for relieving the symptoms of" exact="SARS-CoV-2 infection," post="as proposed in the literature by different research groups"/>
 <result pre="confirmed the use of TCM as a preventive therapy for" exact="SARS-CoV-2 infection." post="Another trial study that is under process is also"/>
 <result pre="pharmaceutical companies enter the race to find a treatment for" exact="SARS-CoV-2 infection," post="relieve its symptoms or to reduce the risk of"/>
 <result pre="2. Therapies in research and development as potential therapies for" exact="SARS-CoV-2 infection." post="Therapies Type Pharmaceutical company Website TJM2 Neutralizing antibody I-Mab"/>
 <result pre="beneficial against certain RNA viruses such as SARS-CoV, MERS-CoV, influenza," exact="Ebola" post="and counter inflammatory medications, as well as product reuse"/>
 <result pre="Med.36(5), 450â€&quot;456 (2016).27374710 35.ShiratoK , YanoT , SenbaSet al.Detection of" exact="Middle East respiratory syndrome" post="coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol."/>
 <result pre="2020 (2020). www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected 70.NicholasJ , BeechingTEF , FowlerRobertBMJ Best Practice:" exact="coronavirus disease 2019" post="(COVID-19) (2020). https://bestpractice.bmj.com/topics/en-gb/3000168 71.FavalliEG , IngegnoliF , DeLucia O"/>
 <result pre=", DongXet al.Epidemiological and clinical characteristics of 99 cases of" exact="2019 novel coronavirus pneumonia" post="in Wuhan, China: a descriptive study. Lancet395(10223), 507â€&quot;513 (2020).32007143"/>
 <result pre="(COVID-19). ww.hse.ie/eng/about/who/acute-hospitals-division/drugs-management-programme/guidelines/specific-antiviral-therapy-in-the-clinical-management-of-acute-respiratory-infection-with-sars-cov-2-covid-19.pdf 78.DongL , HuS , GaoJDiscovering drugs to treat" exact="coronavirus disease 2019" post="(COVID-19). Search Results Featured snippet from the web Drug"/>
 <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitro. Cell. Dis.6(1), 1â€&quot;4 (2020). 101.YaoX , YeF"/>
 <result pre="of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of" exact="COVID19" post=": A Randomized Control Trial (THDMS-COVID19). (2020). https://clinicaltrials.gov/ct2/show/NCT04303299 106.GordonDE"/>
 <result pre="132.RichardsonP , GriffinI , TuckerCet al.Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet395(10223), e30â€&quot;e31 (2020).32032529 133.TanD-X , KorkmazA , ReiterRJ ,"/>
</results>
